Cargando…
Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that slowly destroys memory and thinking skills, resulting in behavioral changes. It is estimated that nearly 36 million are affected globally with numbers reaching 115 million by 2050. AD can only be definitively diagnosed at auto...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357660/ https://www.ncbi.nlm.nih.gov/pubmed/28373857 http://dx.doi.org/10.3389/fneur.2017.00102 |